Literature DB >> 28699016

Position-related renal perfusion disturbances as a possible underestimated mechanism in patients with resistant hypertension: a case vignette.

Jan Schiefer1, Holger Amthauer2,3, Philipp Genseke2, Peter R Mertens4, Christos Chatzikyrkou4.   

Abstract

PURPOSE: In patients with resistant hypertension and large blood pressure fluctuations, the role of orthostatic hypertension, associated with position-dependent renal perfusion disturbances, has not been investigated in detail yet.
METHODS: In this regard, four patients from our outpatient clinic were investigated by the use of 24-h ambulatory blood pressure monitoring (ABPM), active standing test, renal duplex sonography and Tc99m-mercaptoacetyltriglycine [MAG3] renal scintigraphy in supine and upright position.
RESULTS: Four patients (three males and one female; 51-79 years) with a mean of 4.25 antihypertensive drugs including a diuretic were evaluated. The recorded blood pressure fluctuations were up to 89/58-198/121 mmHg. Three patients exhibited an extreme and one a normal dipping pattern in the 24-h ABPM. Three patients demonstrated a hypertensive orthostatic reaction in the active standing test. By duplex sonography, a bilateral decrease in the overall intrarenal resistive indices was shown in two patients, a unilateral overall decrease in one patient and a localized decrease in the last patient. From a morphological standpoint of view, all patients had a normal anatomical position and a physiologic descent of both kidneys. But the normalized tubular extraction rate was pathologic in all patients in the upright body position and normalized when lying down in three patients.
CONCLUSIONS: Position-dependent renal perfusion should be considered in patients with large blood pressure fluctuations and extreme dipping. If morphological imaging shows no abnormalities, functional imaging provides additional information. Further investigation is needed, foremost if nephropexy could improve blood pressure control in some of these patients.

Entities:  

Keywords:  Orthostatic hypertension; Ren mobilis; Renal scintigraphy; Resistant hypertension

Mesh:

Year:  2017        PMID: 28699016     DOI: 10.1007/s11255-017-1656-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  33 in total

Review 1.  Nephroptosis and nephropexy--hung up on the past?

Authors:  N J Barber; P M Thompson
Journal:  Eur Urol       Date:  2004-10       Impact factor: 20.096

Review 2.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 3.  Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine.

Authors:  A T Taylor; J W Fletcher; J V Nally; M D Blaufox; E V Dubovsky; E J Fine; D Kahn; K A Morton; C D Russell; G N Sfakianakis; M Aurell; M Dondi; E Fommei; G Geyskes; G Granerus; H Y Oei
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

4.  Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization.

Authors:  Peng Duan; Shanshan Li; Ni Ai; Longqin Hu; William J Welsh; Guofeng You
Journal:  Mol Pharm       Date:  2012-09-25       Impact factor: 4.939

5.  Laparoscopic nephropexy: 3-year experience.

Authors:  P Fornara; C Doehn; D Jocham
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

6.  [Bilateral determination of 131-I-hippuran clearance in nephroptoses within the scope of sequential camera scintigraphy].

Authors: 
Journal:  Nucl Med (Stuttg)       Date:  1975-06-30

7.  Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development.

Authors:  Noriko Takahara; Tsuneo Saga; Masayuki Inubushi; Hiroyuki Kusuhara; Chie Seki; Sumito Ito; Nobuyuki Oyama; Osamu Yokoyama; Yuichi Sugiyama; Yasuhisa Fujibayashi
Journal:  Nucl Med Biol       Date:  2013-04-22       Impact factor: 2.408

8.  Transport of 99mTc-MAG3 via rat renal organic anion transporter 1.

Authors:  Naoto Shikano; Yoshikatsu Kanai; Keiichi Kawai; Nobuyoshi Ishikawa; Hitoshi Endou
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

9.  Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement.

Authors:  Hemal Bhatt; Mohammed Siddiqui; Eric Judd; Suzanne Oparil; David Calhoun
Journal:  J Am Soc Hypertens       Date:  2016-03-30

10.  Clinical experience with 99mTc-MAG3, mercaptoacetyltriglycine, and a comparison with 99mTc-DTPA.

Authors:  A A Al-Nahhas; R A Jafri; K E Britton; K Solanki; J Bomanji; S Mather; M A Carroll; M Al-Janabi; V Frusciante; B Ajdinowic
Journal:  Eur J Nucl Med       Date:  1988
View more
  1 in total

1.  Orthostatic hypertension: From pathophysiology to clinical applications and therapeutic considerations.

Authors:  Nikolaos Magkas; Costas Tsioufis; Costas Thomopoulos; Polychronis Dilaveris; Georgios Georgiopoulos; Michael Doumas; Dimitris Papadopoulos; Dimitrios Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-06       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.